Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epigenetic Regulation in Melanoma: Facts and Hopes.
Giunta EF, Arrichiello G, Curvietto M, Pappalardo A, Bosso D, Rosanova M, Diana A, Giordano P, Petrillo A, Federico P, Fabozzi T, Parola S, Riccio V, Mucci B, Vanella V, Festino L, Daniele B, Ascierto PA, Ottaviano M, On Behalf Of Scito Youth. Giunta EF, et al. Among authors: festino l. Cells. 2021 Aug 11;10(8):2048. doi: 10.3390/cells10082048. Cells. 2021. PMID: 34440824 Free PMC article. Review.
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.
Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G, Camerlingo R, Capone M, Madonna G, Festino L, Caracò C, Di Monta G, Marone U, Di Marzo M, Grimaldi AM, Mori S, Ciliberto G, Ascierto PA. Mozzillo N, et al. Among authors: festino l. Oncoimmunology. 2015 May 22;4(6):e1008842. doi: 10.1080/2162402X.2015.1008842. eCollection 2015 Jun. Oncoimmunology. 2015. PMID: 26155423 Free PMC article.
PD-L1 expression as a potential predictive biomarker.
Fusi A, Festino L, Botti G, Masucci G, Melero I, Lorigan P, Ascierto PA. Fusi A, et al. Among authors: festino l. Lancet Oncol. 2015 Oct;16(13):1285-7. doi: 10.1016/S1470-2045(15)00307-1. Lancet Oncol. 2015. PMID: 26433815 No abstract available.
Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma.
Simeone E, Grimaldi AM, Festino L, Giannarelli D, Vanella V, Palla M, Curvietto M, Esposito A, Palmieri G, Mozzillo N, Ascierto PA. Simeone E, et al. Among authors: festino l. Oncoimmunology. 2017 Jan 19;6(3):e1283462. doi: 10.1080/2162402X.2017.1283462. eCollection 2017. Oncoimmunology. 2017. PMID: 28405510 Free PMC article.
44 results